Skip to main content

Japanese company opens R&D centre in Basel

| News

Japanese company opens R&D centre in Basel


Idemitsu Kosan is a Japanese petroleum company, but it also develops and manufactures electronic materials. The company is now opening a research and development centre for organic light-emitting diodes in Basel, its first outside of Japan.

Panorama Basel (img: Andreas Zimmermann)

Considerable advances have been made in the use of OLED (organic light-emitting diodes) displays in numerous products, including smartphones and large-screen televisions. For this reason, Idemitsu Kosan has decided to enhance its development capacity in this field by establishing an OLED materials development company in Basel. Idemitsu OLED Materials Europe AG, which is opening in January, will be the company’s second OLED R&D facility. The first is in the city of Sodegaura in Japan, explains the company in a statement.

Idemitsu has been cooperating with BASF Schweiz AG in the OLED field, and the OLED researchers from BASF will now work for Idemitsu in the canton of Basel-Stadt. Switzerland is an ideal location for the new R&D centre because it is a global leader in fine chemical synthesis, which is when compounds or new materials are developed out of elements. Researchers from diverse technical backgrounds will develop Idemitsu’s OLED technology in Basel, thus strengthening this business area.

The location promotion organisation assisted Idemitsu in the search for a suitable location.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

biGENIUS receives 2 million euros for new cloud product

Software company biGENIUS, based in the Basel Area, has secured financing of 2 million euros. This funding was granted following...
Read More

Opterion Health secures investment of 6.5 million Swiss francs

Opterion Health has raised a total of 6.5 million Swiss francs as part of a financing round. The company, which...
Read More

TOLREMO receives 39 million US dollars in investments

TOLREMO Therapeutics has concluded a series A funding round with 39 million US dollars. The biotech company based in Basel...
Read More

Mazars opens tenth Swiss office in Basel

Mazars is now also present in Basel with a subsidiary as of September 1. This is the tenth Swiss location...
Read More

Medtech in Switzerland – bringing together traditional skills and hightech industry

How the intersection of traditional and novel skillsets in the Jura area is propelling Switzerland into a new era of...
Read More

Fondation Botnar supporting further research into pediatric health

The Basel-based Botnar Research Centre for Child Health has received a further donation of 50 million Swiss francs from the...
Read More

Do you have a question? We'd like to hear from you.